Reorienting our view of particle-based adjuvants for subunit vaccines.
作者信息
Little Steven R
机构信息
Departments of Chemical Engineering, Bioengineering, and Immunology, and The McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
出版信息
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):999-1000. doi: 10.1073/pnas.1120993109. Epub 2012 Jan 17.
Abstract
摘要
相似文献
1
Reorienting our view of particle-based adjuvants for subunit vaccines.重新审视用于亚单位疫苗的基于颗粒的佐剂
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):999-1000. doi: 10.1073/pnas.1120993109. Epub 2012 Jan 17.
2
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.用纳米颗粒疫苗增强对疟疾抗原的体液反应，该疫苗可扩增滤泡辅助性 T 细胞并促进生发中心诱导。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1080-5. doi: 10.1073/pnas.1112648109. Epub 2012 Jan 12.
3
Towards a vaccine against Plasmodium vivax malaria.迈向间日疟原虫疟疾疫苗
PLoS Med. 2007 Dec;4(12):e350. doi: 10.1371/journal.pmed.0040350.
4
Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.用人源化佐剂配制的间日疟原虫联合亚单位疫苗在小鼠中的免疫原性。
Vaccine. 2007 Jul 9;25(28):5166-74. doi: 10.1016/j.vaccine.2007.04.080. Epub 2007 May 21.
5
A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.一种基于间日疟原虫顶膜蛋白 1 结构域 II 的重组疫苗可诱导小鼠产生高抗体滴度。
Vaccine. 2010 Aug 31;28(38):6183-90. doi: 10.1016/j.vaccine.2010.07.017. Epub 2010 Jul 21.
6
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.用包含间日疟原虫环子孢子蛋白重复区域和破伤风毒素通用T辅助表位的多抗原构建体（MAC）免疫松鼠猴诱导保护性抗体。
Vaccine. 1997 Mar;15(4):377-86. doi: 10.1016/s0264-410x(97)00200-4.
7
Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.不同佐剂配方的重组间日疟原虫 MSP-10 疫苗接种可诱导强烈的免疫原性，但无保护作用。
Vaccine. 2009 Dec 10;28(1):7-13. doi: 10.1016/j.vaccine.2009.09.046. Epub 2009 Sep 25.
8
Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.间日疟原虫裂殖子表面蛋白1旁系同源物在诱导自然获得性抗体和记忆B细胞反应中的免疫原性。
Malar J. 2017 Aug 30;16(1):354. doi: 10.1186/s12936-017-2000-z.
9
Malaria vaccine development using synthetic peptides as a technical platform.基于合成肽技术平台的疟疾疫苗研发。
Adv Immunol. 2012;114:107-49. doi: 10.1016/B978-0-12-396548-6.00005-6.
10
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.间日疟原虫网织红细胞结合蛋白-1（PvRBP1）重组片段在人体中的抗原性及其在夜猴中的免疫原性和保护研究。
Vaccine. 2007 May 4;25(18):3713-21. doi: 10.1016/j.vaccine.2006.12.041. Epub 2007 Jan 3.
引用本文的文献
1
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles.一种使用嵌合益生菌大肠杆菌膜泡的针对包膜病原体的高免疫原性疫苗平台。
NPJ Vaccines. 2022 Nov 26;7(1):153. doi: 10.1038/s41541-022-00572-z.
2
Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production.自组装的合成纳米佐剂支架交联 B 细胞受体，代表了治疗性抗体生产的新技术平台。
Sci Adv. 2021 Aug 4;7(32). doi: 10.1126/sciadv.abj1691. Print 2021 Aug.
3
Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.利用细胞膜包覆的纳米粒子进行细菌感染的类毒素疫苗接种。
Bioconjug Chem. 2018 Mar 21;29(3):604-612. doi: 10.1021/acs.bioconjchem.7b00692. Epub 2017 Dec 27.
4
Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.采用病毒样特征增强免疫增强作用的纳米颗粒疫苗。
Nanotheranostics. 2017 Jun 9;1(3):244-260. doi: 10.7150/ntno.19796. eCollection 2017.
5
Nanocarrier-based immunotherapy in cancer management and research.基于纳米载体的免疫疗法在癌症管理与研究中的应用
Immunotargets Ther. 2014 Jun 26;3:121-34. doi: 10.2147/ITT.S62471. eCollection 2014.
6
Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.细胞膜包覆纳米颗粒作为一种新兴的抗菌疫苗平台。
Vaccines (Basel). 2015 Oct 6;3(4):814-28. doi: 10.3390/vaccines3040814.
7
Nanoparticle approaches against bacterial infections.对抗细菌感染的纳米颗粒方法。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):532-47. doi: 10.1002/wnan.1282. Epub 2014 Jul 15.
8
Working together: interactions between vaccine antigens and adjuvants.协同作用：疫苗抗原与佐剂之间的相互作用
Ther Adv Vaccines. 2013 May;1(1):7-20. doi: 10.1177/2051013613480144.
9
Porous silicon advances in drug delivery and immunotherapy.多孔硅在药物传递和免疫治疗中的进展。
Curr Opin Pharmacol. 2013 Oct;13(5):834-41. doi: 10.1016/j.coph.2013.06.006. Epub 2013 Jul 8.
10
Particle platforms for cancer immunotherapy.用于癌症免疫治疗的粒子平台。
Int J Nanomedicine. 2013;8:1683-96. doi: 10.2147/IJN.S31756. Epub 2013 Apr 29.
本文引用的文献
1
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.用纳米颗粒疫苗增强对疟疾抗原的体液反应，该疫苗可扩增滤泡辅助性 T 细胞并促进生发中心诱导。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1080-5. doi: 10.1073/pnas.1112648109. Epub 2012 Jan 12.
2
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.层间交联的多层囊泡作为合成疫苗，引发强烈的体液和细胞免疫应答。
Nat Mater. 2011 Mar;10(3):243-51. doi: 10.1038/nmat2960. Epub 2011 Feb 20.
3
Vaccine adjuvants: putting innate immunity to work.疫苗佐剂：充分发挥固有免疫的作用。
Immunity. 2010 Oct 29;33(4):492-503. doi: 10.1016/j.immuni.2010.10.002.
4
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.聚(丙硫醚)纳米粒子通过二硫键连接的肽向树突状细胞传递抗原：交叉呈递和 T 细胞激活。
Vaccine. 2010 Nov 23;28(50):7897-906. doi: 10.1016/j.vaccine.2010.09.077. Epub 2010 Oct 8.
5
Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.疫苗佐剂对 CD4 T 细胞受体多样性的调节。
Immunology. 2010 May;130(1):16-22. doi: 10.1111/j.1365-2567.2010.03265.x. Epub 2010 Mar 17.
6
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.间日疟原虫疟疾的新进展：重症疾病与氯喹耐药性的上升
Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1.
7
Towards an understanding of the adjuvant action of aluminium.关于对铝的佐剂作用的理解。
Nat Rev Immunol. 2009 Apr;9(4):287-93. doi: 10.1038/nri2510.
8
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax.用于生产临床级大肠杆菌重组间日疟原虫疟疾疫苗的工艺开发。
Vaccine. 2009 Feb 25;27(9):1448-53. doi: 10.1016/j.vaccine.2008.12.027. Epub 2009 Jan 10.
9
TLR-mediated cell signaling by malaria GPIs.疟疾糖基磷脂酰肌醇（GPI）介导的Toll样受体（TLR）细胞信号传导
Trends Parasitol. 2007 Dec;23(12):596-604. doi: 10.1016/j.pt.2007.09.003. Epub 2007 Nov 5.
10
Role of target geometry in phagocytosis.靶标几何形状在吞噬作用中的作用。
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4. doi: 10.1073/pnas.0600997103. Epub 2006 Mar 20.
Zotero 插件